Blood clots are gel-like clumps of blood that form in response to an injury or a specific medical condition to help stop bleeding. While clotting is a necessary process that prevents excessive bleeding, unwanted blood clots can pose serious health risks. These clots can occur in various parts of the body and can lead to conditions such as deep vein thrombosis (DVT) when they form in the legs, or pulmonary embolism if they travel to the lungs. Factors that can increase the risk of blood clots include prolonged immobility, certain genetic conditions, surgery, obesity, smoking, and some types of cancer treatments. Symptoms of blood clots depend on their location in the body: clots in the leg can cause swelling, pain, and redness, while clots in the lungs can lead to chest pain, difficulty breathing, and coughing. Treatment typically involves anticoagulants (blood thinners), which reduce the blood’s ability to clot, and measures to prevent the risk of future clots.
Researchers advise that while the absolute risk remains low, women should be informed accordingly. People using non-steroidal anti-inflammatory painkillers in combination with hormonal contraceptives may…
Platelets, or thrombocytes, are specialized cellular fragments that form blood clots when we get scrapes and traumatic injuries. Conditions such as viral infections, autoimmune diseases,…
Researchers have developed a new compound, MPI 8, that offers a safer and more effective blood thinner by targeting a non-essential molecule in blood clotting….
The findings reveal a slight increase in risk after adenovirus vaccines, which should be taken into account when organizing immunization campaigns and planning future vaccine…
SuPAR Identifies Patients at High Risk of Blood Clot Formation A study from a COVID-19 cohort reveals an additional link between the immune system and…
Research uncovered an increased risk of pulmonary embolism (a blood clot in the lung) up to six months after COVID-19 infection, deep vein thrombosis (a…
The finding brings researchers closer to finding the exact cause of inflammation and clotting in severe COVID-19 patients. Scientists have discovered that “rogue” antibodies found…
Two large studies carried out independently in the UK both found a slight increase in risk of intracranial thromboses in some populations after the AstraZeneca…
After studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers, including those who work at the National Institutes of Health, identified…
Scientists have identified how and why some COVID-19 patients can develop life-threatening clots, which could lead to targeted therapies that prevent this from happening. The…
New evidence shows that patients with Long COVID syndrome continue to have higher measures of blood clotting, which may help explain their persistent symptoms, such…
New research highlights the need for heightened awareness and early testing for patients with signs of clotting disorder following vaccination. New research has shown that…
Scientists now understand the mechanism that leads to platelet activation and clotting. A new lifesaving treatment for people suffering from vaccine-related blood clots has been…
Engineering researchers have developed a new technique for eliminating particularly tough blood clots, using engineered nanodroplets and an ultrasound “drill” to break up the clots…